Haleon takes hit from ‘weak' flu season but Sensodyne shines

Haleon Warns Of Cost Increases, But Maintains Outlook

Haleon, the owner of brands such as Sensodyne, Centrum, and Panadol, warned yesterday that it was facing rising costs due to the conflict in the Middle East. However, the British consumer healthcare firm maintained its annual outlook, with performance in (more…) The post Haleon Warns Of Cost Increases, But Maintains Outlook appeared first on KamCity.

Haleon takes hit from ‘weak' flu season but Sensodyne shines

After being spun out from GSK in the biggest London IPO in decades, City analyst are looking for more from the emblematic FTSE 100 consumer healthcare powerhouse with roots in a Lombard Street apothecary shop Fewer sniffles during the winter have sent a chill through sales volumes at Haleon, the FTSE 100 over-the-counter remedy maker. The owner of the Panadol and Day Nurse brands revealed the impact of what it called a “weak cold and flu season”…